# Daniel Fred Goodman, M.D. – FDA Inspection, Nov 25, 2024

Source: https://www.keypedia.com/records/fda_inspections/daniel-fred-goodman-md/2ed39930-450c-4176-b906-735fc2e3c0c9
Source feed: FDA_Inspections

> FDA inspection 1255006 of Daniel Fred Goodman, M.D., November 25, 2024. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255006
- Company Name: Daniel Fred Goodman, M.D.
- Inspection Date: 2024-11-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1159513 - 2021-12-13](https://www.keypedia.com/records/fda_inspections/daniel-fred-goodman-md/936fa295-a792-48b3-9102-1b99c535babc)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)

Company: https://www.keypedia.com/companies/daniel-fred-goodman-md/75721ae4-0e50-488f-bbb5-22b050bc0249

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df
